Potent inhibitors of the hepatitis C virus NS3 protease: Use of a novel P2 cyclopentane-derived template-Reference-Cited by-同舟云学术

Potent inhibitors of the hepatitis C virus NS3 protease: Use of a novel P2 cyclopentane-derived template

Published:2006-08 Issue:15 Volume:14 Page:5136-5151
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Johansson Per-Ola,Bäck Marcus,Kvarnström Ingemar,Jansson Katarina,Vrang Lotta,Hamelink Elizabeth,Hallberg Anders,Rosenquist Åsa,Samuelsson Bertil

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference53 articles.

1. An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis

2. Hepatitis C

3. World Health Organization: Hepatitis C. Seroprevalence of Hepatitis C Virus (HCV) in a Population Sample. Weekly Epidemiol. Rec. 1996, 71, 346–349.

4. A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrocyclic-based strategy in drug design: From lab to the clinic;European Journal of Medicinal Chemistry;2024-11

2. Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?;Journal of Medicinal Chemistry;2024-01-05

3. A concise access to bridged [2,2,1] bicyclic lactones with a quaternary stereocenter via stereospecific hydroformylation;Nature Communications;2021-09-06

4. Drug Syntheses Beyond the Rule of 5;Chemistry – A European Journal;2019-10-11

5. Evolution of HCV NS3/4a Protease Inhibitors;Topics in Medicinal Chemistry;2019